126 related articles for article (PubMed ID: 7805181)
1. Treatment of advanced hormone-refractory prostate carcinoma with a combination of etoposide, pirarubicin and cisplatin.
Naito S; Ueda T; Kotoh S; Kumazawa J; Itoh K; Sagiyama K; Omoto T; Andoh S; Hasegawa Y; Fujisawa Y
Cancer Chemother Pharmacol; 1995; 35(3):225-9. PubMed ID: 7805181
[TBL] [Abstract][Full Text] [Related]
2. Results of a phase II study with doxorubicin, etoposide, and cisplatin in patients with fully characterized small-cell carcinoma of the prostate.
Papandreou CN; Daliani DD; Thall PF; Tu SM; Wang X; Reyes A; Troncoso P; Logothetis CJ
J Clin Oncol; 2002 Jul; 20(14):3072-80. PubMed ID: 12118020
[TBL] [Abstract][Full Text] [Related]
3. Phase II trial of oral estramustine, oral etoposide, and intravenous paclitaxel in hormone-refractory prostate cancer.
Smith DC; Esper P; Strawderman M; Redman B; Pienta KJ
J Clin Oncol; 1999 Jun; 17(6):1664-71. PubMed ID: 10561202
[TBL] [Abstract][Full Text] [Related]
4. Phase II trial of paclitaxel, estramustine, etoposide, and carboplatin in the treatment of patients with hormone-refractory prostate carcinoma.
Smith DC; Chay CH; Dunn RL; Fardig J; Esper P; Olson K; Pienta KJ
Cancer; 2003 Jul; 98(2):269-76. PubMed ID: 12872344
[TBL] [Abstract][Full Text] [Related]
5. Weekly paclitaxel, estramustine phosphate, and oral etoposide in the treatment of hormone-refractory prostate carcinoma: results of a Minnie Pearl Cancer Research Network phase II trial.
Meluch AA; Greco FA; Morrissey LH; Raefsky EL; Steis RG; Butts JA; Hainsworth JD;
Cancer; 2003 Nov; 98(10):2192-8. PubMed ID: 14601089
[TBL] [Abstract][Full Text] [Related]
6. Phase II evaluation of oral estramustine and oral etoposide in hormone-refractory adenocarcinoma of the prostate.
Pienta KJ; Redman B; Hussain M; Cummings G; Esper PS; Appel C; Flaherty LE
J Clin Oncol; 1994 Oct; 12(10):2005-12. PubMed ID: 7523606
[TBL] [Abstract][Full Text] [Related]
7. Chemotherapy for endocrine-therapy-refractory prostate cancer.
Akimoto S; Ohki T; Akakura K; Masai M; Shimazaki J
Cancer Chemother Pharmacol; 1994; 35 Suppl():S18-22. PubMed ID: 7527733
[TBL] [Abstract][Full Text] [Related]
8. Combination of docetaxel, estramustine phosphate, and zoledronic acid in androgen-independent metastatic prostate cancer: efficacy, safety, and clinical benefit assessment.
Efstathiou E; Bozas G; Kostakopoulos A; Kastritis E; Deliveliotis C; Antoniou N; Skarlos D; Papadimitriou C; Dimopoulos MA; Bamias A
Urology; 2005 Jan; 65(1):126-30. PubMed ID: 15667877
[TBL] [Abstract][Full Text] [Related]
9. [Low-dose cisplatin and UFT for hormone refractory prostate cancer].
Hoshi S; Ohyama C; Namiki S; Hagisawa S; Satoh M; Saito S; Ono K; Shirasaka T; Arai Y
Gan To Kagaku Ryoho; 2002 Oct; 29(10):1773-8. PubMed ID: 12402428
[TBL] [Abstract][Full Text] [Related]
10. Effective radiochemotherapy with cisplatin and etoposide for the management of patients with locally inoperable and metastatic esophageal carcinoma.
Hejna M; Kornek GV; Schratter-Sehn AU; Zach M; Schoder M; Raderer M; Rosen H; Schiessel R; Scheithauer W
Cancer; 1996 Oct; 78(8):1646-50. PubMed ID: 8859175
[TBL] [Abstract][Full Text] [Related]
11. Combination chemotherapy with Tegafur. Uracil (UFT), etoposide, adriamycin and cisplatinum (UFT-EAP) for advanced gastric cancer.
Hayakawa M; Morise K; Chin K; Sugihara M; Morooka Y; Maeda H; Hattori T; Saito H
Jpn J Clin Oncol; 1994 Oct; 24(5):282-8. PubMed ID: 7967107
[TBL] [Abstract][Full Text] [Related]
12. Phase II clinical and pharmacological study of pirarubicin in combination with 5-fluorouracil and cyclophosphamide in metastatic breast cancer.
Dhingra K; Frye D; Newman RA; Walters R; Theriault R; Fraschini G; Smith T; Buzdar A; Hortobagyi GN
Clin Cancer Res; 1995 Jul; 1(7):691-7. PubMed ID: 9816034
[TBL] [Abstract][Full Text] [Related]
13. Phase II evaluation of oral estramustine, oral etoposide, and intravenous paclitaxel in patients with hormone-sensitive prostate adenocarcinoma.
Mackler NJ; Pienta KJ; Dunn RL; Cooney KA; Redman BG; Olson KB; Fardig JE; Smith DC
Clin Genitourin Cancer; 2007 Jun; 5(5):318-22. PubMed ID: 17645828
[TBL] [Abstract][Full Text] [Related]
14. [Etoposide, pirarubicin and cisplatin(ETP) combined therapy of inoperable head and neck cancer].
Kawakami T; Watanabe S; Ogawara T; Akagi S; Tamura S; Koide I; Ogawa A; Takiguchi S; Masuda Y
Gan To Kagaku Ryoho; 1993 Apr; 20(5):669-72. PubMed ID: 8470928
[No Abstract] [Full Text] [Related]
15. [Pilot phase II trial of high-dose etoposide combined with cisplatin in the treatment of refractory lung cancer].
Fujita J; Morikawa N; Yamaji Y; Kubo A; Takigawa K; Yamagishi Y; Fujita T; Shiotani T; Takahara J; Irino S
Gan To Kagaku Ryoho; 1992 Jun; 19(6):849-54. PubMed ID: 1318697
[TBL] [Abstract][Full Text] [Related]
16. [Combination chemotherapy of methotrexate, etoposide, adriamycin and cisplatin (M-EAP) for advanced urothelial cancer].
Hashimura T; Okumura K; Akao T; Nakagawa T
Hinyokika Kiyo; 1991 Jul; 37(7):685-8. PubMed ID: 1927767
[TBL] [Abstract][Full Text] [Related]
17. Mitotane associated with etoposide, doxorubicin, and cisplatin in the treatment of advanced adrenocortical carcinoma. Italian Group for the Study of Adrenal Cancer.
Berruti A; Terzolo M; Pia A; Angeli A; Dogliotti L
Cancer; 1998 Nov; 83(10):2194-200. PubMed ID: 9827725
[TBL] [Abstract][Full Text] [Related]
18. [Successful treatment of two patients with advanced gastric cancer by neoadjuvant chemotherapy with EAP regimen].
Matsumura T; Ohnoshi T; Ueoka H; Kiura K; Tabata M; Genba K; Chikamori M; Ikubo S; Matsuo K; Kimura I
Gan To Kagaku Ryoho; 1994 Feb; 21(2):261-4. PubMed ID: 8311499
[TBL] [Abstract][Full Text] [Related]
19. Combination chemotherapy for non-small cell lung cancer with doxorubicin and mitomycin or cisplatin and etoposide.
Joss RA; Alberto P; Obrecht JP; Barrelet L; Holdener EE; Siegenthaler P; Goldhirsch A; Mermillod B; Cavalli F
Cancer Treat Rep; 1984 Sep; 68(9):1079-84. PubMed ID: 6090014
[TBL] [Abstract][Full Text] [Related]
20. A randomized phase II trial of echinomycin, trimetrexate, and cisplatin plus etoposide in patients with metastatic nonsmall cell lung carcinoma: an Eastern Cooperative Oncology Group Study (E1587).
Chang AY; Kim K; Boucher H; Bonomi P; Stewart JA; Karp DD; Blum RH
Cancer; 1998 Jan; 82(2):292-300. PubMed ID: 9445185
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
